You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antithrombin

Showing 1 - 25 of 366
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Antithrombin III Deficiency Trial in Brussel (observation)

Not yet recruiting
  • Antithrombin III Deficiency
  • observation
  • Brussel, Belgium
    UZ Brussel
May 26, 2023

Acquired Antithrombin Deficiency Trial (Human plasma derived antithrombin, Placebo)

Not yet recruiting
  • Acquired Antithrombin Deficiency
  • Human plasma derived antithrombin
  • Placebo
  • (no location specified)
Oct 17, 2023

Antithrombin III Deficiency in Adult Patients With ECMO

Completed
  • Antithrombin III Deficiency
  • Extracorporeal Membrane Oxygenation Complication
  • Antithrombin III
  • Istanbul, Turkey
    Istanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Tra
May 22, 2022

Trauma Injury, Thromboembolism, Venous Thromboembolism Trial in Houston (Thrombate infusion, Placebo)

Not yet recruiting
  • Trauma Injury
  • +2 more
  • Thrombate infusion
  • Placebo
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Mar 28, 2023

Antithrombin III Treatment in Severe COVID-19 Infection

Active, not recruiting
  • Covid19
  • Antithrombin III
  • Innsbruck, Austria
  • +5 more
Aug 1, 2022

Congenital Antithrombin Deficiency Trial in Worldwide (Atenativ)

Recruiting
  • Congenital Antithrombin Deficiency
  • Washington, District of Columbia
  • +13 more
Sep 16, 2022

Portal Vein Thrombosis, Cirrhosis, Liver Trial in Hershey (Antithrombin III, Placebo)

Withdrawn
  • Portal Vein Thrombosis
  • Cirrhosis, Liver
  • Antithrombin III
  • Placebo
  • Hershey, Pennsylvania
    Penn State College of Medicine
Feb 23, 2022

Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)

Active, not recruiting
  • Antithrombin III Deficiency
  • Plasma-derived AT-III concentrate
  • (no location specified)
May 5, 2022

Hemophilia A Trial (Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin

Not yet recruiting
  • Hemophilia A
  • Fitusiran (SAR439774)
  • +3 more
  • (no location specified)
Nov 17, 2023

Disseminated Intravascular Coagulation Trial (Antithrombin alfa (INN name), Control (Standard treatment))

Terminated
Has Results
  • Disseminated Intravascular Coagulation
  • Antithrombin alfa (INN name)
  • Control (Standard treatment)
  • (no location specified)
Aug 5, 2021

Liver Transplantation and Antithrombin Trial in Seoul (Antithrombin III)

Completed
  • Liver Transplantation and Antithrombin
  • Antithrombin III
  • Seoul, Korea, Republic of
    Asan Medical Center
May 30, 2021

Hemophilia Trial in Orange (Fitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate

Recruiting
  • Hemophilia
  • Orange, California
    Center for Inherited Blood Disorders (CIBD)-Site Number:8400012
Feb 2, 2023

Antithrombin Deficiency in Patients of Intensive Care Unit

Completed
  • Severe Cardiac Insufficiency
  • Blood sample
  • Rennes, France
    CHU Rennes
Jun 3, 2021

Hepatic Veno-Occlusive Disease Trial in Seoul (Freeze-dried Concentrated Human Antithrombin ? 500 IU)

Active, not recruiting
  • Hepatic Veno-Occlusive Disease
  • Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU
  • Seoul, Chongno-gu, Korea, Republic of
    Seoul National University Hospital
Mar 28, 2021

Covid19, Severe Acute Respiratory Syndrome, Distress Respiratory Syndrome Trial in Córdoba (Antithrombin + best available

Completed
  • Covid19
  • +2 more
  • Antithrombin + best available treatment
  • Best available treatment
  • Córdoba, Spain
    Hospital Universitario Reina Sofía
Feb 8, 2021

Raloxifene, Postmenopausal Women Trial (coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S,

Completed
  • Raloxifene
  • Postmenopausal Women
  • coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S, antithrombin III and fibrinogen were studied.
  • (no location specified)
Jul 2, 2020

Lack of AT-?, PC, PS Activity and PICC-related Thrombosis

Unknown status
  • Central Venous Catheter Thrombosis
  • Venous blood collecting and test and ultrasound screening
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 30, 2020

Preeclampsia Trial in Japan (Antithrombin gamma, physiological saline)

Recruiting
  • Preeclampsia
  • Antithrombin gamma
  • physiological saline
  • Nagoya, Aichi, Japan
  • +62 more
Nov 16, 2022

Myocardial Infarction Trial in Worldwide (Tenecteplase, Clopidogrel, Coronary angiography)

Active, not recruiting
  • Myocardial Infarction
  • Liverpool, Australia
  • +49 more
Dec 20, 2022

Evaluation of Risk Factors and Outcome of Thrombosis in Children

Not yet recruiting
  • Thrombosis in Children
  • complete blood count
  • Sohag, Egypt
    Sohag University hospitals
Apr 30, 2023

Extracorporeal Membrane Oxygenation Trial in Milano (Antithrombin supplementation, No antithrombin supplementation)

Completed
  • Extracorporeal Membrane Oxygenation
  • Antithrombin supplementation
  • No antithrombin supplementation
  • Milano, MI, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
May 15, 2019

Hemophilia A, Hemophilia B Trial in Worldwide (Fitusiran (SAR439774))

Active, not recruiting
  • Hemophilia A
  • Hemophilia B
  • Fitusiran (SAR439774)
  • Ann Arbor, Michigan
  • +11 more
Aug 4, 2022

ATIII Deficiency Trial in Durham (Anti-thrombin III, Placebo)

Completed
Has Results
  • ATIII Deficiency
  • Anti-thrombin III
  • Placebo
  • Durham, North Carolina
    Duke University
Nov 21, 2019

Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])

Not yet recruiting
  • Liver Cirrhosis
  • Apixaban 5 MG [Eliquis]
  • Edoxaban 60 MG [Lixiana]
  • (no location specified)
May 19, 2023

Hemostatic Profiles in Pediatric CKD

Active, not recruiting
  • Kidney Disease, Chronic
  • +3 more
  • phlebotomy
  • Atlanta, Georgia
    Children's Healthcare of Atlanta - Egleston
Jul 19, 2022